Literature DB >> 29170903

"Where Does it Come from?" Experiences Among Survivors and Parents of Children with Retinoblastoma in Kenya.

Amal Gedleh1, Siwon Lee1, Jessica A Hill2, Yvonne Umukunda3, Seemi Qaiser3, Joy Kabiru4, Kahaki Kimani5,6, Lucy Njambi5,6, Grace Kitonyi5,7, Helen Dimaras8,9,10,11,12,13,14.   

Abstract

Genetic testing and counseling have become integral to the timely control of heritable cancers, like the childhood eye cancer retinoblastoma. This study aimed to determine attitudes, knowledge and experiences related to retinoblastoma genetics, among survivors and parents of children with retinoblastoma in Kenya. This qualitative study used focus groups as the primary data collection method, coupled with a brief demographic questionnaire. Study settings were Kenyatta National Hospital and Presbyterian Church of East Africa Kikuyu Hospital. Thematic analysis was used to identify key themes. Thirty-one individuals participated in five focus groups. Two main concepts emerged: (1) the origins of retinoblastoma are unclear, and (2) retinoblastoma is associated with significant challenges. The lack of clarity surrounding the origins of retinoblastoma was linked to limited knowledge of retinoblastoma genetics, and limited genetic counseling delivery and uptake. The challenges associated with retinoblastoma were discussed in terms of the impact of the diagnosis on individuals and families, and unmet healthcare needs related to the diagnosis. Next steps will incorporate these findings to develop evidence-informed and accessible cancer genetic services in Kenya.

Entities:  

Keywords:  Cancer; Focus groups; Genetics; Inheritance; Kenya; Patient perspectives; Qualitative research; Retinoblastoma

Mesh:

Year:  2017        PMID: 29170903     DOI: 10.1007/s10897-017-0174-8

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  23 in total

1.  Psychosocial consequences of genetic counseling: a population-based follow-up study.

Authors:  Ellen M Mikkelsen; Lone Sunde; Christoffer Johansen; Søren P Johnsen
Journal:  Breast J       Date:  2008-12-12       Impact factor: 2.431

2.  Capacity-building in human genetics for developing countries: initiatives and perspectives in sub-Saharan Africa.

Authors:  A Wonkam; W Muna; R Ramesar; C N Rotimi; M J Newport
Journal:  Public Health Genomics       Date:  2010-03-23       Impact factor: 2.000

3.  [Retinoblastoma in Kenya: survival and prognostic factors].

Authors:  E N Gichigo; M M Kariuki-Wanyoike; K Kimani; M M Nentwich
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

Review 4.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

5.  Developing clinical cancer genetics services in resource-limited countries: the case of retinoblastoma in Kenya.

Authors:  Li Qun He; Lucy Njambi; Joseph M Nyamori; Emmanuel M Nyenze; Kahaki Kimani; Ibrahim Matende; Hilary Rono; Victor Njom; James Bett; Mukiri Mukuria; Muchai Gachago; Helen Roberts; Helen Dimaras
Journal:  Public Health Genomics       Date:  2014-07-19       Impact factor: 2.000

6.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10

7.  Prenatal versus Postnatal Screening for Familial Retinoblastoma.

Authors:  Sameh E Soliman; Helen Dimaras; Vikas Khetan; Jane A Gardiner; Helen S L Chan; Elise Héon; Brenda L Gallie
Journal:  Ophthalmology       Date:  2016-10-03       Impact factor: 12.079

8.  Cancer genetic counselor information needs for risk communication: a qualitative evaluation of interview transcripts.

Authors:  Casey Lynnette Overby; Wendy K Chung; George Hripcsak; Rita Kukafka
Journal:  J Pers Med       Date:  2013

9.  American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss.

Authors:  Raye L Alford; Kathleen S Arnos; Michelle Fox; Jerry W Lin; Christina G Palmer; Arti Pandya; Heidi L Rehm; Nathaniel H Robin; Daryl A Scott; Christine Yoshinaga-Itano
Journal:  Genet Med       Date:  2014-03-20       Impact factor: 8.822

10.  Achieving optimal cancer outcomes in East Africa through multidisciplinary partnership: a case study of the Kenyan National Retinoblastoma Strategy group.

Authors:  Jessica A Hill; Kahaki Kimani; Abby White; Faith Barasa; Morgan Livingstone; Brenda L Gallie; Helen Dimaras
Journal:  Global Health       Date:  2016-05-26       Impact factor: 4.185

View more
  5 in total

Review 1.  Improving health and social systems for all children in LMICs: structural innovations to deliver high-quality services.

Authors:  Margaret E Kruk; Todd P Lewis; Catherine Arsenault; Zulfiqar A Bhutta; Grace Irimu; Joshua Jeong; Zohra S Lassi; Susan M Sawyer; Tyler Vaivada; Peter Waiswa; Aisha K Yousafzai
Journal:  Lancet       Date:  2022-04-27       Impact factor: 202.731

2.  Parent Knowledge of Screening and Genetic Testing in Retinoblastoma.

Authors:  Wei Xiao; Xian Ji; Huijing Ye; Huiqi Zeng; Yang Gao; Rongxin Chen; Xiaoyun Chen; Yuxiang Mao; Huasheng Yang
Journal:  J Ophthalmol       Date:  2020-04-08       Impact factor: 1.909

3.  Paroxysmal Kinesigenic Dyskinesia: First Molecularly Confirmed Case from Africa.

Authors:  Marieke C J Dekker; Rose Chengo; Happiness H Kumburu; Erik-Jan Kamsteeg; Ben C Hamel
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-01-10

4.  Opportunities and barriers for genetic service delivery in Kenya from a health personnel perspective.

Authors:  Adrina Zhong; Kaiwen Xia; Zissis Hadjis; Gavin Lifman; Lucy Njambi; Helen Dimaras
Journal:  J Community Genet       Date:  2021-07-06

5.  Children's and adolescents' experiences of healthcare professionals: scoping review protocol.

Authors:  Gail Davison; Martina Ann Kelly; Andrew Thompson; Tim Dornan
Journal:  Syst Rev       Date:  2020-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.